Log in to search using one of your social media accounts:

 

Prostate problem? Take 2 nuts
By age 60, you have a 50/50 chance of having a clinically enlarged prostate. And it only gets worse every year. When your prostate isn’t functioning properly, it’s hard to enjoy life. Traditional doctors give you two choices. Go under the knife or you take Big Pharma’s drugs. Either way, you have a good chance of ending up with your manhood on the line… If you have surgery, there’s a big risk you’ll be saying goodbye to your sex life for good. The rate of impotence is a shocking 50 to 60% after prostate surgery.1 Big Pharma’s meds to shrink your prostate are no better. These sy...
Source: Al Sears, MD Natural Remedies - October 19, 2017 Category: Complementary Medicine Authors: Cathy Card Tags: Anti-Aging Source Type: news

Dutasteride vs. Finasteride (Side Effects, Dosage, Use)
Title: Dutasteride vs. Finasteride (Side Effects, Dosage, Use)Category: MedicationsCreated: 9/27/2017 12:00:00 AMLast Editorial Review: 9/28/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - September 28, 2017 Category: Drugs & Pharmacology Source Type: news

Dutasteride Associated With Metabolic Safety Concerns
Use of medication in BPH linked to higher hemoglobin A1c and LDL cholesterol levels (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 30, 2017 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Geriatrics, Internal Medicine, Nursing, Oncology, Pathology, Pharmacy, Urology, Journal, Source Type: news

Some Prostate Drugs May Do Harm
THURSDAY, June 29, 2017 -- Popular hormone-based drugs for treating an enlarged prostate could increase men's risk of type 2 diabetes, heart disease or stroke, a new study suggests. A group of German men taking the drug Avodart (dutasteride) for... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 29, 2017 Category: General Medicine Source Type: news

Popular prostate drug linked to serious side effects
(Boston University Medical Center) Treatment of benign prostatic hyperplasia (BPH) with the commonly prescribed Avodart (Dutsteride) may put men at an increased risk for diabetes, elevated cholesterol levels, non-alcoholic fatty liver disease (NAFLD) and worsening erectile dysfunction. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 22, 2017 Category: International Medicine & Public Health Source Type: news

Duagen (Dutasteride) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 3, 2017 Category: Drugs & Pharmacology Source Type: news

Hair loss drugs linked with erectile dysfunction
This study aimed to see whether the duration of exposure has an effect, and whether it persists after stopping the drugs.   What did the research involve? The study included men from the Chicago region who had taken 5α-RIs. Electronic medical records were accessed to look at the drug, dose, and duration of use. Researchers searched the database for recorded side effects of impotence or erectile dysfunction. This was defined as the first recorded instance, which coincided with discontinuation of the 5α-RI and prescription of a phosphodiesterase -5 inhibitors (PDE5I), such as sildenafil to treat the problem....
Source: NHS News Feed - March 13, 2017 Category: Consumer Health News Tags: Medication Lifestyle/exercise Source Type: news

Finasteride, Dutasteride Don't Seem to Increase Risk for Erectile Dysfunction (FREE)
By Amy Orciari Herman Edited by Andr é Sofair, MD, MPH, and William E. Chavey, MD, MS The 5-alpha reductase inhibitors finasteride and dutasteride do not appear to increase risk for erectile dysfunction in men with benign prostatic hyperplasia … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 22, 2016 Category: Primary Care Source Type: news

Avodart (Dutasteride) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 14, 2016 Category: Drugs & Pharmacology Source Type: news

Avodart & Proscar for Treating Prostate...
(Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - March 7, 2016 Category: Cancer & Oncology Tags: health Source Type: news

Strides Shasun gets USFDA nod to market Dutasteride capsules
The company has received approval from the US Food and Drug Administration (USFDA) to market Dutasteride capsules in the strength of 0.5 mg, Strides Shasun said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 21, 2015 Category: Pharmaceuticals Source Type: news

Teva Announces Exclusive Launch of Generic Avodart(R) Capsules in the United States
JERUSALEM--(Healthcare Sales & Marketing Network)--Teva Pharmaceutical Industries Ltd., (TEVA) today announced the exclusive launch of the generic equivalent to Avodart® (dutasteride) capsules, 0.5 mg, in the United States. Dutasteride is a 5 alpha-red... Biopharmaceuticals, Urology, Generics, Product LaunchTeva Pharmaceutical, Avodart, dutasteride, benign prostatic hyperplasia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 12, 2015 Category: Pharmaceuticals Source Type: news

Adverse effects of common prostate enlargement and hair growth drugs
Twenty-five percent of men currently taking Finasteride or Dutasteride, popularly known as Proscar and Avodart, for the treatment of benign prostate enlargement, appear not to benefit from taking these medications. Those prescribed Propecia or Avodart for male pattern hair loss (known as alopecia) are also at risk for adverse events elicited by these drugs. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 25, 2015 Category: Science Source Type: news

Adverse effects of common prostate enlargement and hair growth drugs: A review
(Boston University Medical Center) Twenty-five percent of men currently taking Finasteride or Dutasteride, popularly known as Proscar and Avodart, for the treatment of benign prostate enlargement, appear not to benefit from taking these medications. Those prescribed Propecia or Avodart for male pattern hair loss (known as alopecia) are also at risk for adverse events elicited by these drugs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 25, 2015 Category: Global & Universal Source Type: news

Avodart & Proscar for Treating Prostate...
Avodart and Proscar are FDA-approved for treating urinary side effects from prostate enlargement. Does it have anti-cancer effects and is it safe? (Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - April 20, 2015 Category: Cancer & Oncology Tags: health Source Type: news

dutasteride (Avodart)
Title: dutasteride (Avodart)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 12/22/2014 12:00:00 AM (Source: MedicineNet Mens Health General)
Source: MedicineNet Mens Health General - December 22, 2014 Category: Primary Care Source Type: news

Dutasteride Plus Tamsulosin vs Tamsulosin Alone for BPHDutasteride Plus Tamsulosin vs Tamsulosin Alone for BPH
This study assesses the economic value of tamsulosin alone or combined with dutasteride for the treatment of BPH. Which is more cost-effective? BMC Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 27, 2014 Category: Consumer Health News Tags: Urology Journal Article Source Type: news

Global and Chinese Dutasteride Industry (CAS 164656-23-9) 2019...
ReportsnReports.com adds Latest Report on “Market Research Report on Global and Chinese Dutasteride(CAS 164656-23-9) Industry, 2009-2019” to its store. Complete report is available at...(PRWeb July 27, 2014)Read the full story at http://www.prweb.com/releases/dutasteride-market/2019-global-and-chinese/prweb12047308.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 27, 2014 Category: Pharmaceuticals Source Type: news

Cancer Headlines from Johns Hopkins (with audio)
(MedPage Today) -- This month's topics include long-term follow-up on finasteride and dutasteride, lung cancer and air pollution, molecular reclassification of brain tumors, and a decision on cells from Henrietta Lacks. (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 4, 2013 Category: Hematology Source Type: news

Should You Use Avodart to Reduce Risk of...
Should you use Avodart to reduce your risk of prostate cancer? Avodart (otherwise known as dutasteride) has been used extensively in the past to treat men with benign prostatic hyperplasia (BPH). Learn more about it here. (Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - June 23, 2013 Category: Cancer & Oncology Tags: health Source Type: news

Dutasteride (Avodart) and Prostate Cancer
Dutasteride and Prostate Cancer - Dutasteride (Avodart) is a drug that has recently been shown to reduce the risk of developing certain types of prostate cancer. But what else do we know about dutasteride (Avodart) and is it a good idea to take it to prevent prostate cancer? (Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - June 10, 2013 Category: Cancer & Oncology Tags: health Source Type: news

New Lawsuit on Avodart High-Grade Prostate Cancer: Now, AttorneyOne...
According to court documents, on February 4th, 2013, a woman filed a lawsuit in Jefferson County District Court alleging her husband developed high-grade prostate cancer from Avodart and died. In...(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10427605.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news

REDUCE follow up study of dutasteride for prostate cancer risk reduction
Source: J Urology Area: News The original 4 year REDUCE (REduction by DUtasteride of prostate Cancer Events) trial evaluated dutasteride (0.5mg daily) for prostate cancer risk reduction in men at increased risk for prostate cancer (older age, increased PSA levels) found that dutasteride reduced the relative risk of biopsy detectable prostate cancer by 22.8% (95% CI 15.2-29.8) compared with placebo.   In the current REDUCE Follow-Up Study, 2,751 of the original participants were followed up for an additional two years during which time no drugs were provided and all biopsies were performed for cause. The primary e...
Source: NeLM - News - January 30, 2013 Category: Drugs & Pharmacology Source Type: news

Follow-Up To REDUCE Study Shows Low Rate Of Prostate Cancer Diagnosis
Analysis of 2 Years of Additional Data on Dutasteride Treatment Reported in The Journal of Urology® The four-year REDUCE (REduction by DUtasteride of prostate Cancer Events) clinical study evaluated prostate cancer risk reduction in men taking dutasteride, a 5-alpha-reductase inhibitor (5ARI) typically used to treat enlarged prostate. REDUCE results showed that dutasteride decreased the risk of biopsy detectable prostate cancer by 22.8 percent compared to a placebo group, but concerns remained about the drug's effectiveness... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 24, 2013 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

Follow-up to REDUCE study shows low rate of prostate cancer diagnosis
(Elsevier Health Sciences) The four-year REDUCE (REduction by DUtasteride of prostate Cancer Events) clinical study evaluated prostate cancer risk reduction in men taking dutasteride, a 5-alpha-reductase inhibitor typically used to treat enlarged prostate. REDUCE results showed that dutasteride decreased the risk of biopsy detectable prostate cancer by 22.8 percent compared to a placebo group, but concerns remained about the drug's effectiveness. Results from a follow-up study are now published in the Journal of Urology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 22, 2013 Category: Cancer & Oncology Source Type: news

New Lawsuit on Avodart Prostate Cancer: Now, AttorneyOne Can Provide...
According to court documents, on December 6th, 2012, a Texas resident and his wife filed a lawsuit in Pennsylvania Eastern District Court alleging he developed prostate cancer from his use of the drug...(PRWeb December 31, 2012)Read the full story at http://www.prweb.com/releases/2012/12/prweb10278666.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 1, 2013 Category: Pharmaceuticals Source Type: news